NuSkin Enterprises (NUS) Earnings Date & Reports

Key Takeaways

• Third quarter revenue came in at $311.0 million, within the company's guidance range but down 14.6% from $364.2 million in the prior-year period.
• Reported diluted earnings per share (EPS) was a loss of $(0.02); excluding organizational transition and other charges, EPS was $0.10, in line with guidance.
• Gross margin declined to 65.0% from 70.5% a year ago, largely reflecting the revenue mix between the core Nu Skin and Rhyz businesses.
• Customer, paid affiliate, and sales leader counts all fell double digits year over year, signaling ongoing pressure on the company's direct-selling model.
• Management guided fourth-quarter revenue of $310 million to $340 million and adjusted EPS of $0.11 to $0.21, while full-year 2026 revenue is projected at $1.26 billion to $1.29 billion.
• For more on Nu Skin's Major News, Today's Price Move, Price Targets, and Forecast, explore these dedicated pages.
• Discover Trending AI Robots to explore AI-driven trading strategies and market signals.

Earnings Context and Why It Matters

Nu Skin Enterprises, a global beauty and wellness company operating in nearly 50 markets, has spent 2026 restructuring its business through a new East-West operating model while contending with softer demand across its direct-selling channel. The third quarter offered investors a fresh look at whether those cost initiatives are gaining traction against a still-declining top line. Prior quarters showed steep year-over-year revenue declines, and this report was closely watched for signs of stabilization in customer and affiliate engagement. Because the company's sales force drives much of its growth, metrics such as customers, paid affiliates, and sales leaders matter as much as revenue. The results help clarify whether management's efficiency efforts and product platform investments are positioning Nu Skin for the sequential growth it has signaled for the fourth quarter.

Reported Results

Nu Skin reported third-quarter 2026 revenue of $311.0 million, within its guidance range but down 14.6% from $364.2 million a year earlier. On a constant-currency basis, revenue fell 13.5%, with foreign exchange accounting for about a 1.1% headwind, or $3.9 million. Reported diluted EPS was a loss of $(0.02), compared with a profit of $0.34 in the prior-year quarter. Excluding organizational transition costs tied to the East-West operating model and other charges, adjusted EPS was $0.10, which management said was in line with its guidance range. Gross margin compressed to 65.0% from 70.5%, reflecting the mix between the higher-margin core Nu Skin business and the Rhyz ecosystem; core Nu Skin gross margin was 76.6%, down from 77.7%. Selling expenses improved to 33.2% of revenue from 35.8%, while general and administrative expenses declined $10.9 million year over year. Adjusted operating margin was 3.7%, down from 5.9% a year earlier. The company ended the quarter with $164.9 million in cash and cash equivalents and total debt of $203.7 million.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is built to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, making it a useful companion for earnings-season research. Investors looking to monitor how names like Nu Skin respond to quarterly results can explore the platform to surface relevant signals and ideas.

Market Reaction and Investor Sentiment

Nu Skin's results drew a mixed market response, as reported figures came in below some consensus expectations. According to Investing.com, analysts had modeled EPS around $0.32 and revenue near $375.5 million, meaning the adjusted EPS of $0.10 and revenue of $311.0 million fell short of those estimates. Shares, which closed at $4.53, traded lower in after-hours action following the release. Investor sentiment remains cautious, weighed down by the continued contraction in the customer and affiliate base and the sharp year-over-year decline in core Nu Skin revenue. At the same time, management's commentary struck a forward-looking tone, pointing to a successful Nu Skin LIVE global convention in Japan and sequential growth expected in the fourth quarter. The tension between near-term sales erosion and longer-term restructuring benefits is likely to keep the stock range-bound until investors see clearer evidence of stabilization.

Forward Outlook and Key Factors to Monitor

For the fourth quarter of 2026, Nu Skin guided revenue of $310 million to $340 million, implying a year-over-year decline of roughly 16% to 8%, with an anticipated foreign-currency tailwind of about 1%. Reported EPS is expected in the range of $0.05 to $0.15, or $0.11 to $0.21 on an adjusted basis. For the full year, management now projects revenue of $1.26 billion to $1.29 billion and adjusted EPS of $0.55 to $0.65.

The reported full-year EPS outlook remains heavily negative—between $(5.08) and $(4.98)—because of non-cash items including a second-quarter goodwill impairment and a deferred tax valuation allowance, neither of which affected the company's cash position or ability to execute its strategic plan. Investors should therefore focus on adjusted figures and cash-based metrics when assessing underlying performance.

Looking ahead, several factors warrant monitoring. First, management expects approximately $5 million in remaining cash-based organizational transition costs in the fourth quarter as it completes the East-West operating model rollout. Second, the planned formal launch in India represents a meaningful potential catalyst for the sales channel in 2027. Third, gross margin improvement initiatives—pricing discipline, product mix optimization, and operational efficiency—will be tested against a still-soft demand backdrop. Finally, sustained engagement of customers and affiliates during the holiday season will be key to confirming the sequential growth management has signaled.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations